Drug Pricing
Commentary
A Look At The Democrats’ Not-So-Moderate Healthcare Platform
At their virtual convention this week, Democrats went to great lengths to communicate that they were united in their quest to defeat President Trump. Health care would appear to be the exception to that spirit of unity. More than 700 delegates to the Democratic National Convention said beforehand they’d oppose ...
Sally C. Pipes
August 28, 2020
Blog
What We’re Watching – August 28
Ben Smithwick – Helping Citizens Understand a World without Fossil Fuels Ronald Stein, co-author of the new book Just GREEN Electricity – Helping Citizens Understand a World without Fossil Fuels, discusses the dangers of overreliance on renewable energy. Click here to watch the video Tim Anaya – Making Biosimilars and ...
Pacific Research Institute
August 28, 2020
Commentary
Valuing Innovative Drugs Based On Their Cost Of Manufacturing Will Prolong The Covid-19 Pandemic
The value of innovative medicines has absolutely nothing to do with its cost of production. Yet, not only does this myth persist, it appears to be growing. In the latest example, an article in the Journal of Virus Eradication claims that drugs being repurposed in the hopes they might be effective treatments for ...
Wayne Winegarden
August 14, 2020
Blog
What We’re Watching – August 14
Tim Anaya – Reforming Patient Costs at the Pharmacy In the latest video in the Pacific Research Institute “Escape the Drug Pricing Maze” series, the Professor and Pete must collect 3 keys to finally escape the drug pricing maze. The first key involves reforms to increase drug affordability for patients ...
Pacific Research Institute
August 14, 2020
Blog
What We’re Watching – July 31
Rowena Itchon – A Tribute to Herman Cain https://youtu.be/2qeFfGpJ2m8 Kerry Jackson – Ricky Gervais gives the ‘cancel culture cretins’ a massive serve “Just because you’re offended, doesn’t make you right,” comedian Ricky Gervais says. He could have also said that just because you’re offended, it doesn’t give you the right to ...
Pacific Research Institute
July 31, 2020
Commentary
Trump’s drug pricing executive orders harmful to patients — will hinder development of new drugs
President Trump issued four executive orders Friday that he said will lower drug prices — but in reality, three of the orders will cause far more harm than good and represent electioneering at its worst. The three harmful executive orders allow the importation of drugs from Canada, reduce the price ...
Sally C. Pipes
July 24, 2020
Drug Pricing
Sally Pipes and Lars Larson Examine Trump Ex. Orders on Drug Pricing
Sally C. Pipes joins the Lars Larson Show to question the Trump administration’s latest action on drug pricing. President Trump plans to sign an executive order on Friday, July 24 that puts limits on drug pricing in the United States. Pipes explains that 90 percent of drugs are generic and ...
Sally C. Pipes
July 24, 2020
Commentary
Executive Order On Drug Price Controls Would Backfire
Rumor has it that President Trump will soon issue a sweeping executive order to lower prescription drug prices by fiat. Nothing is set in stone. But the order would reportedly index the government’s reimbursements for medicines to the prices that Britain, France, Canada, and other developed nations pay. Since all those nations ...
Sally C. Pipes
July 22, 2020
Commentary
Patients Will Suffer The Most From The Trump Administration’s Reference Pricing Scheme
The pharmaceutical industry has responded to the Covid-19 pandemic with, arguably, the greatest surge in drug innovation in history. Consider that Remdesivir (produced by Gilead) has already received an emergency use authorization by the FDA for Covid-19. Losmapimod (produced by Fulcrum) is another promising treatment for Covid-19 that is in Phase III trials. And, ...
Wayne Winegarden
July 20, 2020
Drug Pricing
What We’re Watching – July 17
Rowena Itchon – 102-year-old woman survives 1918 pandemic, COVID-19 Gerri Schappals is 102, and survived the Spanish flu, cancer, and COVID-19 – an inspiration to us all. Ben Smithwick – The Black Swan Economy Jonathan Coslet, Senior Partner & Chief Investment Officer at TPG Capital, and Stanford Professor John B. ...
Pacific Research Institute
July 17, 2020
A Look At The Democrats’ Not-So-Moderate Healthcare Platform
At their virtual convention this week, Democrats went to great lengths to communicate that they were united in their quest to defeat President Trump. Health care would appear to be the exception to that spirit of unity. More than 700 delegates to the Democratic National Convention said beforehand they’d oppose ...
What We’re Watching – August 28
Ben Smithwick – Helping Citizens Understand a World without Fossil Fuels Ronald Stein, co-author of the new book Just GREEN Electricity – Helping Citizens Understand a World without Fossil Fuels, discusses the dangers of overreliance on renewable energy. Click here to watch the video Tim Anaya – Making Biosimilars and ...
Valuing Innovative Drugs Based On Their Cost Of Manufacturing Will Prolong The Covid-19 Pandemic
The value of innovative medicines has absolutely nothing to do with its cost of production. Yet, not only does this myth persist, it appears to be growing. In the latest example, an article in the Journal of Virus Eradication claims that drugs being repurposed in the hopes they might be effective treatments for ...
What We’re Watching – August 14
Tim Anaya – Reforming Patient Costs at the Pharmacy In the latest video in the Pacific Research Institute “Escape the Drug Pricing Maze” series, the Professor and Pete must collect 3 keys to finally escape the drug pricing maze. The first key involves reforms to increase drug affordability for patients ...
What We’re Watching – July 31
Rowena Itchon – A Tribute to Herman Cain https://youtu.be/2qeFfGpJ2m8 Kerry Jackson – Ricky Gervais gives the ‘cancel culture cretins’ a massive serve “Just because you’re offended, doesn’t make you right,” comedian Ricky Gervais says. He could have also said that just because you’re offended, it doesn’t give you the right to ...
Trump’s drug pricing executive orders harmful to patients — will hinder development of new drugs
President Trump issued four executive orders Friday that he said will lower drug prices — but in reality, three of the orders will cause far more harm than good and represent electioneering at its worst. The three harmful executive orders allow the importation of drugs from Canada, reduce the price ...
Sally Pipes and Lars Larson Examine Trump Ex. Orders on Drug Pricing
Sally C. Pipes joins the Lars Larson Show to question the Trump administration’s latest action on drug pricing. President Trump plans to sign an executive order on Friday, July 24 that puts limits on drug pricing in the United States. Pipes explains that 90 percent of drugs are generic and ...
Executive Order On Drug Price Controls Would Backfire
Rumor has it that President Trump will soon issue a sweeping executive order to lower prescription drug prices by fiat. Nothing is set in stone. But the order would reportedly index the government’s reimbursements for medicines to the prices that Britain, France, Canada, and other developed nations pay. Since all those nations ...
Patients Will Suffer The Most From The Trump Administration’s Reference Pricing Scheme
The pharmaceutical industry has responded to the Covid-19 pandemic with, arguably, the greatest surge in drug innovation in history. Consider that Remdesivir (produced by Gilead) has already received an emergency use authorization by the FDA for Covid-19. Losmapimod (produced by Fulcrum) is another promising treatment for Covid-19 that is in Phase III trials. And, ...
What We’re Watching – July 17
Rowena Itchon – 102-year-old woman survives 1918 pandemic, COVID-19 Gerri Schappals is 102, and survived the Spanish flu, cancer, and COVID-19 – an inspiration to us all. Ben Smithwick – The Black Swan Economy Jonathan Coslet, Senior Partner & Chief Investment Officer at TPG Capital, and Stanford Professor John B. ...